Status:
COMPLETED
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
Lead Sponsor:
Eli Lilly and Company
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purposes of this study are to determine: * The safety of duloxetine and any side effects that might be associated with it. * How duloxetine compares to escitalopram and placebo (an inactive ingre...
Detailed Description
duloxetine 60mg - 120mg, escitalopram 10mg - 20mg, and placebo, 8-month,
Eligibility Criteria
Inclusion
- Must be at least 18 of age
- Must meet the criteria for major depressive disorder
- You must be able to visit the doctor's office about once a week for 2 to 3 months. After that, you will need to visit the doctor's office once a month for about 6 months
- You must be able to take the study drug as prescribed (6 capsules per day taken once-daily)
Exclusion
- You are a woman and are pregnant or breastfeeding.
- You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
- You have a history of alcohol or drug dependence within the past 6 months
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
675 Patients enrolled
Trial Details
Trial ID
NCT00073411
Start Date
November 1 2003
End Date
May 1 2005
Last Update
July 31 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Cincinnati, Ohio, United States